減損損失 - 医薬品、投資有価証券売却益、休止設備費用他1件
- 【期間】
| 年度 | 減損損失 - 医薬品 | 投資有価証券売却益 | 休止設備費用 | その他 |
|---|
| 2008/03 | - | | 67.2億 | | - | | - | |
| 2009/03 | - | | 8.58億 | -87.2% | - | | - | |
| 2010/03 | - | | 95.1億 | 大幅増 | - | | - | |
| 2012/03 | - | | 98.4億 | +3.5% | 12.2億 | | - | |
| 2013/03 | 4.3億 | | - | | 28億 | +130% | - | |
| 2014/03 | 70.9億 | 大幅増 | 34.1億 | -65.3% | 24.6億 | -12% | - | |
| 2015/03 | 53.1億 | -25.1% | 40.9億 | +19.8% | 33億 | +33.9% | - | |
| 2016/03 | 5.53億 | -89.6% | 158億 | +287.1% | 32.1億 | -2.6% | - | |
| 2017/03 | - | | 273億 | +72.4% | 33.9億 | +5.5% | - | |
| 2018/03 | - | | 56億 | -79.5% | 23.2億 | -31.6% | 14.2億 | |
| 2019/03 | - | | - | | 13.3億 | -42.8% | 5.94億 | -58.2% |
| 2020/03 | - | | 37.2億 | -33.6% | 17.2億 | +29.5% | 21.3億 | +258.1% |
| 2021/03 | - | | 195億 | +425.1% | 19.2億 | +11.7% | 30.9億 | +45.2% |
| 2022/03 | - | | 61.2億 | -68.6% | 13.2億 | -31% | 69.5億 | +125% |
| 2023/03 | - | | 72.3億 | +18% | 13.8億 | +4.5% | 16.3億 | -76.6% |
| 2024/03 | - | | 299億 | +313.1% | 38.6億 | +179.6% | 9.57億 | -41.1% |
